46 results on '"Mikelis, Constantinos M."'
Search Results
2. Angiopoietin-2-induced lymphatic endothelial cell migration drives lymphangiogenesis via the β1 integrin-RhoA-formin axis
3. Chlorinated benzothiadiazines inhibit angiogenesis through suppression of VEGFR2 phosphorylation
4. Targeting the Angiopoietin/Tie Pathway: Prospects for Treatment of Retinal and Respiratory Disorders
5. Advanced bioinformatic analysis and pathway prediction of NSCLC cells upon cisplatin resistance
6. Stable Dual miR-143 and miR-506 Upregulation Inhibits Proliferation and Cell Cycle Progression.
7. Murine Dermal Lymphatic Endothelial Cell Isolation
8. Abstract 3759: Impact of individual and combined deregulation of miR-143 and miR-506 on cytokinetic and morphometric parameters in A549 lung cancer cells
9. Supplemental Figure 6 from Genetic Identification of SEMA3F as an Antilymphangiogenic Metastasis Suppressor Gene in Head and Neck Squamous Carcinoma
10. Data from Genetic Identification of SEMA3F as an Antilymphangiogenic Metastasis Suppressor Gene in Head and Neck Squamous Carcinoma
11. Supplemental Figure 1 from Genetic Identification of SEMA3F as an Antilymphangiogenic Metastasis Suppressor Gene in Head and Neck Squamous Carcinoma
12. Supplementary Movie 1 from Genetic Identification of SEMA3F as an Antilymphangiogenic Metastasis Suppressor Gene in Head and Neck Squamous Carcinoma
13. Supplementary Figures 1-6 from Decreased Lymphangiogenesis and Lymph Node Metastasis by mTOR Inhibition in Head and Neck Cancer
14. Supplementary Movie 4 from Genetic Identification of SEMA3F as an Antilymphangiogenic Metastasis Suppressor Gene in Head and Neck Squamous Carcinoma
15. Supplemental Figure 2 from Genetic Identification of SEMA3F as an Antilymphangiogenic Metastasis Suppressor Gene in Head and Neck Squamous Carcinoma
16. Supplementary Movie 3 from Genetic Identification of SEMA3F as an Antilymphangiogenic Metastasis Suppressor Gene in Head and Neck Squamous Carcinoma
17. Data from Decreased Lymphangiogenesis and Lymph Node Metastasis by mTOR Inhibition in Head and Neck Cancer
18. Supplemental Figure 4 from Genetic Identification of SEMA3F as an Antilymphangiogenic Metastasis Suppressor Gene in Head and Neck Squamous Carcinoma
19. Supplementary Methods and Materials, Supplementary Figure Legends from Decreased Lymphangiogenesis and Lymph Node Metastasis by mTOR Inhibition in Head and Neck Cancer
20. Supplemental Figure 5 from Genetic Identification of SEMA3F as an Antilymphangiogenic Metastasis Suppressor Gene in Head and Neck Squamous Carcinoma
21. Supplemental Figure 3 from Genetic Identification of SEMA3F as an Antilymphangiogenic Metastasis Suppressor Gene in Head and Neck Squamous Carcinoma
22. Endothelial-Specific Targeting of RhoA Signaling via CD31 Antibody-Conjugated Nanoparticles
23. Genetic deletion or tyrosine phosphatase inhibition of PTPRZ1 activates c‐Met to up‐regulate angiogenesis and lung adenocarcinoma growth.
24. Chlorotoxin and Lung Cancer: A Targeting Perspective for Drug Delivery
25. Human Dectin-1 deficiency impairs macrophage-mediated defense against phaeohyphomycosis
26. Endothelial‐specific nanodelivery of Rho kinase inhibitors: Targeting tumor angiogenesis and metastasis
27. Evaluation of Urea-Based Inhibitors of the Dopamine Transporter Using the Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis
28. Protein tyrosine phosphatase receptor-ζ1 deletion triggers defective heart morphogenesis in mice and zebrafish
29. MiRNAs as Anti-Angiogenic Adjuvant Therapy in Cancer: Synopsis and Potential
30. Protein tyrosine phosphatase receptor-ξ1 deletion triggers defective heart morphogenesis in mice and zebrafish.
31. Cell–Extracellular Matrix Adhesions in Vascular Endothelium
32. Leading Roles of Heparan Sulfate in Angiogenesis and Cancer
33. Hypoxia: A Potent Regulator of Angiogenesis Through Extracellular Matrix Remodelling
34. Kruppel-Like Factor 2 and Matrix Metalloproteinases in the Context of Vasculature
35. Fibronectin Fibrillogenesis During Angiogenesis
36. Extracellular Matrix Remodeling Enzymes as Targets for Natural Antiangiogenic Compounds
37. Collagens and Collagen-Degrading Enzymes in the Regulation of Angiogenesis
38. The Role of Pericytes in Tumor Angiogenesis
39. Endothelial Cell–Matrix Interactions in Angiogenesis and Vessel Homeostasis: A Focus on Laminins and Their Integrin Receptors
40. Functional Interplay Between Fibronectin and Matricellular Proteins in the Control of Endothelial Tubulogenesis
41. Lymphatic Mechanoregulation in Development and Disease
42. The Role of Soluble CD163 (sCD163) in Human Physiology and Pathophysiology.
43. Tumor-induced endothelial RhoA activation mediates tumor cell transendothelial migration and metastasis.
44. Comprehensive analysis of lipid nanoparticle formulation and preparation for RNA delivery.
45. Mechanistic Aspects of Biphenyl Urea-Based Analogues in Triple-Negative Breast Cancer Cell Lines.
46. Protein tyrosine phosphatase receptor-ζ1 deletion triggers defective heart morphogenesis in mice and zebrafish.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.